Guangdong Taiantang Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Guangdong Taiantang Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Guangdong Taiantang Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Held to maturity investment8,2000.0562015-06-30historic
Goodwill445,075,2770.05829802015-06-30historic
Long term accounts payable108,510,8210.014211402015-06-30historic
Construction materials3,384,6154.4E-41442015-09-30historic
Purchases of fixed assets and others222,212,3720.02911802015-09-30historic
Proceeds from sell of investment271,000,0000.035491992015-06-30historic
Refunds of taxes17,815,0780.002332382015-09-30historic
Special reserve786,7801.0E-42712015-09-30historic
Interest receivable706,1759.0E-53192015-06-30historic
Long term borrowings208,330,0000.027283872015-09-30historic
Comprehensive income attributable to minority shareholders2,309,8883.0E-43912015-06-30historic
Minority interests gain2,309,8883.0E-43952015-06-30historic
Prepayment120,340,3320.015764102015-09-30historic
Fixed assets1,145,810,8070.150064152015-09-30historic
Notes receivable80,159,9180.01054152015-09-30historic
Accounts payable467,563,6740.061234212015-09-30historic
Capital reserve1,067,855,7330.139854282015-09-30historic
Total non-current assets2,147,459,5010.281244552015-09-30historic
Investment income from associate and joint venture-597,798-8.0E-54642015-09-30historic
Intangible assets164,942,4530.02165072015-09-30historic
Minority interest73,563,7820.009635132015-06-30historic
Other receivables48,964,7850.006415222015-09-30historic
Long term equity investment38,570,4400.005055412015-09-30historic
Short term borrowings345,000,0000.045185522015-09-30historic
Cash outflows from operating activities1,111,669,0080.145595592015-09-30historic
Cash inflows from operating activities1,111,342,7620.145545662015-09-30historic
Interests payable1,015,0321.3E-45792015-09-30historic
Cash inflows from financing activities520,000,0000.06816012015-09-30historic
Total cost of goods sold880,972,3900.115376182015-09-30historic
Financial expenses11,282,7520.001486302015-09-30historic
Inventories400,793,1490.052496392015-09-30historic
Total liabilities1,485,601,8560.194566392015-09-30historic
Total liabilities and equity3,458,288,7010.452916972015-09-30historic
Revenue786,326,4900.102987122015-09-30historic
Payroll payable13,602,1500.001787312015-09-30historic
Selling expenses26,484,6070.003477742015-09-30historic
Non-operating loss409,2075.0E-58082015-09-30historic
Other payables31,184,0380.004088652015-09-30historic
Other current assets7,488,0399.8E-48682015-09-30historic
Cash paid for dividends, profits or interests21,490,4740.002819312015-09-30historic
Deferred tax assets7,539,7059.9E-49422015-09-30historic
Net cashflow from financing activities-49,660,474-0.00659702015-09-30historic
Net cash flows from investing activities-216,239,070-0.0283210162015-09-30historic
Cash paid for taxes26,850,7610.0035210402015-09-30historic
Diluted eps-00.010512015-09-30historic
Net cash and cash equivalents ending balance151,139,5100.0197911112015-09-30historic
Net change in cash-263,487,365-0.0345111942015-09-30historic
Total comprehensive income-64,024,862-0.0083812762015-09-30historic
Net income-64,024,862-0.0083812792015-09-30historic
Total profit-65,087,149-0.0085212842015-09-30historic
Operating profit-89,391,382-0.0117112852015-09-30historic